<?xml version='1.0' encoding='UTF-8'?>
<rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:webfeeds="http://webfeeds.org/rss/1.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:content="http://purl.org/rss/1.0/modules/content/" version="2.0">
  <channel>
    <title>eLife: latest articles by subject</title>
    <link>https://elifesciences.org</link>
    <description>Articles published by eLife, filtered by given subjects</description>
    <atom:link href="https://observer.elifesciences.org/report/latest-articles-by-subject" rel="self"/>
    <docs>http://www.rssboard.org/rss-specification</docs>
    <generator>observer (using python-feedgen)</generator>
    <language>en</language>
    <lastBuildDate>Fri, 09 Oct 2026 14:31:02 +0000</lastBuildDate>
    <webfeeds:analytics id="G-TZ0BM7CV5E" engine="GoogleAnalytics"/>
    <item>
      <title>NK2R signaling governs intestinal lipid mobilization and mucosal inflammation</title>
      <link>https://elifesciences.org/articles/109903</link>
      <description>Neuropeptidergic control of lipid metabolism is conserved and increasingly implicated in metabolic diseases, but receptor-level mechanisms remain unclear. Here, we identify the neurokinin-2 receptor (NK2R) as a central node linking tachykinin signals to intestinal lipid mobilization, epithelial composition, and mucosal inflammation. Across complementary genetic and pharmacological perturbations, modulation of NK2R drives bidirectional effects. Loss or blockade of NK2R increases postprandial triglyceridemia and expands intestinal lipid stores, whereas agonism suppresses chylomicron output, reduces adiposity, and improves glycemia in diet-induced obesity. Transcriptomic and cellular analyses indicate coordinated upregulation of lipid-metabolic programs with a concomitant dampening of immune pathways in the absence of NK2R, accompanied by sex-specific remodeling of secretory lineages and male-biased protection from colitis. NK2R signaling also shaped the fecal microbiota in a genotype- and diet-dependent manner, highlighting crosstalk among neuropeptide signaling, epithelial physiology, and host-microbe interactions. These findings position NK2R as a molecular switch for intestinal lipid handling and mucosal inflammation and suggest that NK2R-targeted agonists or antagonists could be deployed as context- and sex-dependent therapeutic strategies for metabolic disease and inflammatory bowel disease.</description>
      <author>supriya@scripps.edu (Alessandra Ferrari)</author>
      <author>supriya@scripps.edu (Chung-Chih Liu)</author>
      <author>supriya@scripps.edu (Emma Marie Robinson)</author>
      <author>supriya@scripps.edu (John Paul Kennelly)</author>
      <author>supriya@scripps.edu (Jon Athanacio)</author>
      <author>supriya@scripps.edu (Nicole K Littlejohn)</author>
      <author>supriya@scripps.edu (Pedro A Perez)</author>
      <author>supriya@scripps.edu (Peter Tontonoz)</author>
      <author>supriya@scripps.edu (Sean B Joesph)</author>
      <author>supriya@scripps.edu (Supriya Srinivasan)</author>
      <author>supriya@scripps.edu (Vân TB Nguyen-Tran)</author>
      <author>supriya@scripps.edu (Zaid Amso)</author>
      <guid isPermaLink="false">https://dx.doi.org/10.7554/eLife.109903</guid>
      <category>Genetics and Genomics</category>
      <category>Physiology</category>
      <pubDate>Mon, 05 Oct 2026 00:00:00 +0000</pubDate>
      <dc:date>2026-10-05T00:00:00Z</dc:date>
      <webfeeds:featuredImage url="https://elife-cdn.s3.amazonaws.com/observer/elife-logo-408x230.svg" height="230" width="408" type="image/svg"/>
    </item>
    <item>
      <title>Sex-biased expression of enteroendocrine cell-derived hormones contributes to higher fat storage in &lt;i&gt;Drosophila&lt;/i&gt; females</title>
      <link>https://elifesciences.org/articles/109426</link>
      <description>Enteroendocrine (EE) cells in the &lt;i&gt;Drosophila&lt;/i&gt; gut produce and release multiple factors, including Allatostatin A (AstA), Allatostatin C (AstC), neuropeptide F (NPF), tachykinin (Tk), Diuretic hormone 31 (Dh31), Bursicon, CCHamide 1, CCHamide 2, and short neuropeptide F. Collectively, these peptides ensure that physiology (e.g., fat storage, fluid balance) and behavior (e.g., feeding, sleep) are coordinated with environmental factors such as nutrient quantity and quality. Despite notable sex differences in physiology and behavior, it remains unclear whether the regulation and function of these EE cell-derived factors are shared between males and females. Given that recent data identified sex-biased physiological effects of two EE cell-derived hormones on &lt;i&gt;Drosophila&lt;/i&gt; food intake and energy mobilization, we performed a detailed characterization of these hormones in male and female flies. Despite an overall male bias in mRNA levels of &lt;i&gt;AstA&lt;/i&gt;, &lt;i&gt;AstC&lt;/i&gt;, &lt;i&gt;Tk&lt;/i&gt;, &lt;i&gt;NPF&lt;/i&gt;, and &lt;i&gt;Dh31&lt;/i&gt; in whole-body and head samples, we observed a strong female bias in mRNA levels of &lt;i&gt;AstC&lt;/i&gt;, &lt;i&gt;Tk&lt;/i&gt;, and &lt;i&gt;NPF&lt;/i&gt; in the gut. To determine whether this sex-biased regulation was physiologically significant, we monitored triglyceride levels in flies with gut-specific knock-down of EE cell-derived hormones. In 5-day-old flies, knock-down of EE cell-derived &lt;i&gt;AstC&lt;/i&gt; significantly reduced fat storage in females with no effect in males, whereas knock-down of EE cell-derived &lt;i&gt;Tk&lt;/i&gt; produced a non-significant trend toward reduced fat storage in females. These female-specific effects on fat storage were reproduced in flies with neuron-specific knock-down of the AstC (&lt;i&gt;AstC-R2&lt;/i&gt;) and Tk receptors (&lt;i&gt;TkR99D&lt;/i&gt;). Together, these data uncover strongly sex-biased regulation of EE cell-derived hormones and show that gut-specific knock-down of at least one of these hormones had a female-specific effect on body fat.</description>
      <author>elizabeth.rideout@ubc.ca (Elizabeth J Rideout)</author>
      <author>elizabeth.rideout@ubc.ca (Puja Biswas)</author>
      <guid isPermaLink="false">https://dx.doi.org/10.7554/eLife.109426</guid>
      <category>Physiology</category>
      <pubDate>Thu, 01 Oct 2026 00:00:00 +0000</pubDate>
      <dc:date>2026-10-01T00:00:00Z</dc:date>
      <webfeeds:featuredImage url="https://elife-cdn.s3.amazonaws.com/observer/elife-logo-408x230.svg" height="230" width="408" type="image/svg"/>
    </item>
    <item>
      <title>Probing relaxed myosin states in hypertrophic cardiomyopathy by second harmonic-generation microscopy</title>
      <link>https://elifesciences.org/articles/107730</link>
      <description>This study explores the use of polarized second-harmonic generation (pSHG) to investigate myosin conformation in the relaxed state, differentiating between the actin-available, disordered (ON) state and the energy-conserving, ordered (OFF) state. By shifting the ON/OFF equilibrium using both physical and chemical manipulations, we demonstrate the sensitivity of pSHG in quantifying the ON/OFF ratio in skeletal and cardiac tissues. Comparisons with X-ray diffraction measurements further validate our findings. Applying this approach to a sarcomeric mutation associated with hypertrophic cardiomyopathy, we show that R403Q/MYH7-mutated minipig ventricle tissue exhibits a higher ON fraction compared to controls. This difference is abolished under high concentrations of a myosin activator (2-deoxyATP) and an inhibitor (Mavacamten), indicating structural similarity between R403Q and controls in these two states. ATPase assays reveal increased resting ATPase activity in R403Q samples, which persists even in the presence of 2-deoxyATP, suggesting that the elevated energy consumption in the R403Q mutation is driven by both a population shift toward the ON state and enhanced myosin ATPase activity per motor head.</description>
      <author>leonardo.sacconi@cnr.it (Beatrice Scellini)</author>
      <author>leonardo.sacconi@cnr.it (Caroline Muellenbroich)</author>
      <author>leonardo.sacconi@cnr.it (Cecilia Ferrantini)</author>
      <author>leonardo.sacconi@cnr.it (Chiara Tesi)</author>
      <author>leonardo.sacconi@cnr.it (Corrado Poggesi)</author>
      <author>leonardo.sacconi@cnr.it (Francesco Sera)</author>
      <author>leonardo.sacconi@cnr.it (Giulia Arecchi)</author>
      <author>leonardo.sacconi@cnr.it (Jingyuan Yu)</author>
      <author>leonardo.sacconi@cnr.it (Jing Zhao)</author>
      <author>leonardo.sacconi@cnr.it (Leonardo Sacconi)</author>
      <author>leonardo.sacconi@cnr.it (Marica Dente)</author>
      <author>leonardo.sacconi@cnr.it (Marina Scardigli)</author>
      <author>leonardo.sacconi@cnr.it (Michael Regnier)</author>
      <author>leonardo.sacconi@cnr.it (Nicoletta Piroddi)</author>
      <author>leonardo.sacconi@cnr.it (Riccardo Cicchi)</author>
      <author>leonardo.sacconi@cnr.it (Ryo Kinegawa)</author>
      <author>leonardo.sacconi@cnr.it (Thomas C Irving)</author>
      <author>leonardo.sacconi@cnr.it (Weikang Ma)</author>
      <guid isPermaLink="false">https://dx.doi.org/10.7554/eLife.107730</guid>
      <category>Physiology</category>
      <category>Structural Biology and Molecular Biophysics</category>
      <pubDate>Mon, 17 Aug 2026 00:00:00 +0000</pubDate>
      <dc:date>2026-08-17T00:00:00Z</dc:date>
      <webfeeds:featuredImage url="https://elife-cdn.s3.amazonaws.com/observer/elife-logo-408x230.svg" height="230" width="408" type="image/svg"/>
    </item>
    <item>
      <title>Gene dosage imbalance disrupts systemic metabolism in the Dp16 Down syndrome mouse model</title>
      <link>https://elifesciences.org/articles/110476</link>
      <description>Gene dosage imbalance resulting from an extra copy of human chromosome 21 (Hsa21) contributes to numerous clinical features in Down syndrome (DS). While dysregulated metabolism has long been noted in DS, the underlying cause is poorly understood and vastly understudied. To fill this critical knowledge gap, we conducted a comprehensive metabolic analysis of Dp(16)1Yey/+mice (abbreviated Dp16), a segmental duplication model carrying ~58% of the triplicated Hsa21 gene orthologs. Our multi-tissue transcriptomic analyses reveal shared and sex-specific increases in expression dosage of the triplicated genes in white and brown adipose tissues, liver, skeletal muscle, and hypothalamus. Despite sexual dimorphism in body weight, body temperature, food intake, and physical activity, Dp16 males and females share striking core phenotypes of pronounced insulin resistance, glucose intolerance, impaired lipid clearance, and dyslipidemia. Functional assessments, combined with biochemical, transcriptomic, and metabolomic analyses reveal tissue signatures of immune activation and a pro-inflammatory state, ER and oxidative stress, fibrosis, impaired glucose and fatty acid catabolism, altered lipid and bile acid profiles, and reduced mitochondrial respiratory capacity in Dp16 mice. These concerted changes disrupt homeostatic mechanisms that underpin metabolic health, contributing to systemic metabolic dysfunction. An obesogenic diet further exacerbates insulin resistance in Dp16 males and females despite divergent weight gain. The collective phenotypes broadly reflect the metabolic profile of DS. Our extensive molecular, biochemical, and physiological data provide an essential foundation for genetic dissection of dosage-sensitive genes affecting glucose and lipid metabolism, and for testing therapeutic strategies to improve metabolic outcomes in DS.</description>
      <author>gwwong@jhmi.edu (Christy M Nguyen)</author>
      <author>gwwong@jhmi.edu (Dylan C Sarver)</author>
      <author>gwwong@jhmi.edu (Fangluo Chen)</author>
      <author>gwwong@jhmi.edu (G William Wong)</author>
      <author>gwwong@jhmi.edu (Marcus M Seldin)</author>
      <author>gwwong@jhmi.edu (Muzna Saqib)</author>
      <author>gwwong@jhmi.edu (Susan Aja)</author>
      <author>gwwong@jhmi.edu (Y Eugene Yu)</author>
      <guid isPermaLink="false">https://dx.doi.org/10.7554/eLife.110476</guid>
      <category>Chromosomes and Gene Expression</category>
      <category>Physiology</category>
      <pubDate>Mon, 03 Aug 2026 00:00:00 +0000</pubDate>
      <dc:date>2026-08-03T00:00:00Z</dc:date>
      <webfeeds:featuredImage url="https://elife-cdn.s3.amazonaws.com/observer/elife-logo-408x230.svg" height="230" width="408" type="image/svg"/>
    </item>
    <item>
      <title>Cellular characterization of the mouse collecting lymphatic vessels reveals that lymphatic muscle cells are the innate pacemaker cells</title>
      <link>https://elifesciences.org/articles/90679</link>
      <description>Collecting lymphatic vessels (cLVs) exhibit spontaneous contractions with a pressure-dependent frequency, but the identity of the lymphatic pacemaker cell is still debated. Here, we combined immunofluorescence and scRNAseq analyses with electrophysiological methods to examine the cellular constituents of the mouse cLV wall and assess whether any cell type exhibited morphological and functional processes characteristic of pacemaker cells. We employed inducible Cre mouse models to target-specific cell populations including CkitCreER&lt;sup&gt;T2&lt;/sup&gt; to target interstitial cells of Cajal-like cells, PdgfrβCreER&lt;sup&gt;T2&lt;/sup&gt; to target pericyte-like cells; PdgfrαCreER&lt;sup&gt;TM&lt;/sup&gt; to target CD34&lt;sup&gt;+&lt;/sup&gt; adventitial cells; and Myh11CreER&lt;sup&gt;T2&lt;/sup&gt; to target lymphatic muscle cells (LMCs) directly. These inducible Cre lines were crossed to the fluorescent reporter &lt;i&gt;Rosa26&lt;sup&gt;mTmG&lt;/sup&gt;&lt;/i&gt;, the genetically encoded Ca&lt;sup&gt;2+&lt;/sup&gt; sensor GCaMP6f, and the light-activated cation channel rhodopsin2 (ChR2). Only LMCs consistently, but heterogeneously, displayed spontaneous Ca&lt;sup&gt;2+&lt;/sup&gt; events during the diastolic period of the contraction cycle, and whose frequency was modulated in a pressure-dependent manner. Further, optogenetic depolarization with ChR2 induced propagated contractions only in LMCs. Membrane potential recordings in LMCs demonstrated that the rate of diastolic depolarization significantly correlated with contraction frequency. These findings support the conclusion that LMCs, or a subset of LMCs, are responsible for mouse cLV pacemaking.</description>
      <author>zawiejas@umsystem.edu (Advaya Patro)</author>
      <author>zawiejas@umsystem.edu (Bernard T Drumm)</author>
      <author>zawiejas@umsystem.edu (Charles E Norton)</author>
      <author>zawiejas@umsystem.edu (Grace A Pea)</author>
      <author>zawiejas@umsystem.edu (Hae Jin Kim)</author>
      <author>zawiejas@umsystem.edu (Jorge A Castorena-Gonzalez)</author>
      <author>zawiejas@umsystem.edu (Karen H Bromert)</author>
      <author>zawiejas@umsystem.edu (Michael J Davis)</author>
      <author>zawiejas@umsystem.edu (Min Li)</author>
      <author>zawiejas@umsystem.edu (Sarah E Broyhill)</author>
      <author>zawiejas@umsystem.edu (Sathesh Kumar Sivasankaran)</author>
      <author>zawiejas@umsystem.edu (Scott D Zawieja)</author>
      <guid isPermaLink="false">https://dx.doi.org/10.7554/eLife.90679</guid>
      <category>Cell Biology</category>
      <category>Physiology</category>
      <pubDate>Thu, 11 Sep 2025 00:00:00 +0000</pubDate>
      <dc:date>2025-09-11T00:00:00Z</dc:date>
      <webfeeds:featuredImage url="https://elife-cdn.s3.amazonaws.com/observer/elife-logo-408x230.svg" height="230" width="408" type="image/svg"/>
    </item>
    <item>
      <title>Closing in on pacemaker cells</title>
      <link>https://elifesciences.org/articles/108102</link>
      <description>Lymphatic muscle cells orchestrate the contraction of collecting lymphatic vessels in mice.</description>
      <author>tpadera@steele.mgh.harvard.edu (Pin-Ji Lei)</author>
      <author>tpadera@steele.mgh.harvard.edu (Timothy P Padera)</author>
      <guid isPermaLink="false">https://dx.doi.org/10.7554/eLife.108102</guid>
      <category>Cell Biology</category>
      <category>Physiology</category>
      <pubDate>Tue, 22 Jul 2025 00:00:00 +0000</pubDate>
      <dc:date>2025-07-22T00:00:00Z</dc:date>
      <webfeeds:featuredImage url="https://elife-cdn.s3.amazonaws.com/observer/elife-logo-408x230.svg" height="230" width="408" type="image/svg"/>
    </item>
    <item>
      <title>TRPV4 activation by TGFβ2 enhances cellular contractility and drives ocular hypertension</title>
      <link>https://elifesciences.org/articles/104894</link>
      <description>The risk for developing primary open-angle glaucoma (POAG) correlates with the magnitude of ocular hypertension (OHT) and the concentration of transforming growth factor-β2 (TGFβ2) in the aqueous humor. Effective treatment of POAG requires a detailed understanding of the interaction between pressure sensing mechanisms in the trabecular meshwork (TM) and biochemical risk factors. Here, we employed molecular, optical, electrophysiological, and tonometric strategies to establish the role of TGFβ2 in transcription and functional expression of mechanosensitive channel isoforms alongside studies of TM contractility in biomimetic hydrogels and intraocular pressure (IOP) regulation in a mouse model of TGFβ2-induced OHT. TGFβ2 upregulated expression of &lt;i&gt;Trpv4&lt;/i&gt; and &lt;i&gt;Piezo1&lt;/i&gt; transcripts and time-dependently augmented functional TRPV4 activation. TRPV4 agonists induced contractility of TM-seeded hydrogels, whereas pharmacological inhibition suppressed TGFβ2-induced hypercontractility and abrogated OHT in eyes overexpressing TGFβ2. &lt;i&gt;Trpv4&lt;/i&gt;-deficient mice resisted TGFβ2-driven increases in IOP, but nocturnal OHT was not additive to TGFβ-evoked OHT. Our study establishes the fundamental role of TGFβ as a modulator of mechanosensing in nonexcitable cells, identifies the TRPV4 channel as the final common mechanism for TM contractility and circadian and pathological OHT, and offers insights for future treatments that can lower IOP in the sizeable cohort of hypertensive glaucoma patients that resist current treatments.</description>
      <author>david.krizaj@hsc.utah.edu (Ayushi Singh)</author>
      <author>david.krizaj@hsc.utah.edu (Christopher Nass Rudzitis)</author>
      <author>david.krizaj@hsc.utah.edu (David Krizaj)</author>
      <author>david.krizaj@hsc.utah.edu (Denisa Kirdajová)</author>
      <author>david.krizaj@hsc.utah.edu (Michael L De Ieso)</author>
      <author>david.krizaj@hsc.utah.edu (Monika Lakk)</author>
      <author>david.krizaj@hsc.utah.edu (Samuel Herberg)</author>
      <author>david.krizaj@hsc.utah.edu (Sarah N Redmon)</author>
      <author>david.krizaj@hsc.utah.edu (W Daniel Stamer)</author>
      <author>david.krizaj@hsc.utah.edu (Yun-Ting Tseng)</author>
      <guid isPermaLink="false">https://dx.doi.org/10.7554/eLife.104894</guid>
      <category>Neuroscience</category>
      <category>Physiology</category>
      <pubDate>Tue, 24 Jun 2025 00:00:00 +0000</pubDate>
      <dc:date>2025-06-24T00:00:00Z</dc:date>
      <webfeeds:featuredImage url="https://elife-cdn.s3.amazonaws.com/observer/elife-logo-408x230.svg" height="230" width="408" type="image/svg"/>
    </item>
    <item>
      <title>SLC35G1 is a highly chloride-sensitive transporter responsible for the basolateral membrane transport in intestinal citrate absorption</title>
      <link>https://elifesciences.org/articles/98853</link>
      <description>The intestinal absorption of essential nutrients, especially those not readily biosynthesized, is a critical physiological process for maintaining homeostasis. Numerous studies have indicated that intestinal absorption is mediated by various membrane transporters. Citrate, a crucial bioactive compound produced as an intermediate in the Krebs cycle, is absorbed in the small intestine through carrier-mediated systems because of its high hydrophilicity. While the luminal absorption of citrate is mediated by Na&lt;sup&gt;+&lt;/sup&gt;-dicarboxylate cotransporter 1 (NaDC1/SLC13A2), the mechanism governing the release of the transported citrate into the bloodstream remains unknown. Here, we explored the transporters responsible for intestinal citrate absorption at the basolateral membrane, focusing on highly expressed orphan transporters in the small intestine as candidates. Consequently, SLC35G1, originally identified as a partner of stromal interaction molecule 1, a cell surface transmembrane glycoprotein, was found to play a role in the intestinal absorption of citrate at the basolateral membrane. Furthermore, our results revealed that SLC35G1-mediated citrate transport was diminished by chloride ions at physiologically relevant extracellular concentrations. This suggests that SLC35G1, to our best knowledge, is the first transporter identified to be extremely sensitive to chloride ions among those functioning on the basolateral membrane of intestinal epithelial cells. This study provides valuable insights into the intestinal absorption of citrate and significantly contributes to elucidating the poorly understood molecular basis of the intestinal absorption system.</description>
      <author>yasujima@phar.nagoya-cu.ac.jp (Chitaka Namba)</author>
      <author>yasujima@phar.nagoya-cu.ac.jp (Hiroaki Yuasa)</author>
      <author>yasujima@phar.nagoya-cu.ac.jp (Hiroyuki Kusuhara)</author>
      <author>yasujima@phar.nagoya-cu.ac.jp (Katsuhisa Inoue)</author>
      <author>yasujima@phar.nagoya-cu.ac.jp (Kinya Ohta)</author>
      <author>yasujima@phar.nagoya-cu.ac.jp (Shogo Akino)</author>
      <author>yasujima@phar.nagoya-cu.ac.jp (Takahiro Yamashiro)</author>
      <author>yasujima@phar.nagoya-cu.ac.jp (Tomoya Yasujima)</author>
      <author>yasujima@phar.nagoya-cu.ac.jp (Yoshihisa Mimura)</author>
      <author>yasujima@phar.nagoya-cu.ac.jp (Yutaro Sekiguchi)</author>
      <guid isPermaLink="false">https://dx.doi.org/10.7554/eLife.98853</guid>
      <category>Biochemistry and Chemical Biology</category>
      <category>Physiology</category>
      <pubDate>Thu, 07 Nov 2024 00:00:00 +0000</pubDate>
      <dc:date>2024-11-07T00:00:00Z</dc:date>
      <webfeeds:featuredImage url="https://elife-cdn.s3.amazonaws.com/observer/elife-logo-408x230.svg" height="230" width="408" type="image/svg"/>
    </item>
    <item>
      <title>Mechano-regulation of GLP-1 production by Piezo1 in intestinal L cells</title>
      <link>https://elifesciences.org/articles/97854</link>
      <description>Glucagon-like peptide 1 (GLP-1) is a gut-derived hormone secreted by intestinal L cells and vital for postprandial glycemic control. As open-type enteroendocrine cells, whether L cells can sense mechanical stimuli caused by chyme and thus regulate GLP-1 synthesis and secretion is unexplored. Molecular biology techniques revealed the expression of Piezo1 in intestinal L cells. Its level varied in different energy status and correlates with blood glucose and GLP-1 levels. Mice with L cell-specific loss of Piezo1 (&lt;i&gt;Piezo1&lt;/i&gt; IntL-CKO) exhibited impaired glucose tolerance, increased body weight, reduced GLP-1 production and decreased CaMKKβ/CaMKIV-mTORC1 signaling pathway under normal chow diet or high-fat diet. Activation of the intestinal Piezo1 by its agonist Yoda1 or intestinal bead implantation increased the synthesis and secretion of GLP-1, thus alleviated glucose intolerance in diet-induced-diabetic mice. Overexpression of Piezo1, Yoda1 treatment or stretching stimulated GLP-1 production and CaMKKβ/CaMKIV-mTORC1 signaling pathway, which could be abolished by knockdown or blockage of Piezo1 in primary cultured mouse L cells and STC-1 cells. These experimental results suggest a previously unknown regulatory mechanism for GLP-1 production in L cells, which could offer new insights into diabetes treatments.</description>
      <author>chenh567@mail.sysu.edu.cn (Geyang Xu)</author>
      <author>chenh567@mail.sysu.edu.cn (Haocong Mo)</author>
      <author>chenh567@mail.sysu.edu.cn (Hening Zhai)</author>
      <author>chenh567@mail.sysu.edu.cn (Hui Chen)</author>
      <author>chenh567@mail.sysu.edu.cn (Jie Yang)</author>
      <author>chenh567@mail.sysu.edu.cn (Jinghui Guo)</author>
      <author>chenh567@mail.sysu.edu.cn (Jingya Lyu)</author>
      <author>chenh567@mail.sysu.edu.cn (Linyan Zhu)</author>
      <author>chenh567@mail.sysu.edu.cn (Luyang Gao)</author>
      <author>chenh567@mail.sysu.edu.cn (Qimeng Wang)</author>
      <author>chenh567@mail.sysu.edu.cn (Qing Shu)</author>
      <author>chenh567@mail.sysu.edu.cn (Tian Tao)</author>
      <author>chenh567@mail.sysu.edu.cn (Wenying Guo)</author>
      <author>chenh567@mail.sysu.edu.cn (Yanling Huang)</author>
      <author>chenh567@mail.sysu.edu.cn (Yawen Zhao)</author>
      <guid isPermaLink="false">https://dx.doi.org/10.7554/eLife.97854</guid>
      <category>Medicine</category>
      <category>Physiology</category>
      <pubDate>Thu, 07 Nov 2024 00:00:00 +0000</pubDate>
      <dc:date>2024-11-07T00:00:00Z</dc:date>
      <webfeeds:featuredImage url="https://elife-cdn.s3.amazonaws.com/observer/elife-logo-408x230.svg" height="230" width="408" type="image/svg"/>
    </item>
  </channel>
</rss>
